Weill Cornell Medicine Receives $1.27m Funding to Develop Treatment for Rare Eye Disease

The US Department of Defense (DoD) has awarded Weill Cornell Medicine a $1.27 million grant to develop a treatment for a rare but deadly eye disease that mostly affects military members who have suffered traumatic eye injuries in combat.

Weill Cornell Medicine Receives $1.27m Funding to Develop Treatment for Rare Eye Disease
November 23, 2021
Oculentis Declares Bankruptcy After its Intraocular Lenses Result in Serious Vision Loss

Oculentis B.V. has been declared bankrupt by order of the District Court Gelderland of September 6, 2021. Mr. E.R. Looijen is the bankruptcy trustee, and Mr. M.J.C. van Leeuwen is the delegated judge.

Oculentis Declares Bankruptcy After its Intraocular Lenses Result in Serious Vision Loss
November 24, 2021
Hilco Vision Acquires Simovision BV, Distributor of Ophthalmic Products

Hilco Vision announced the acquisition of Belgium and Netherlands-based Simovision BV as of November 17, 2021.

Hilco Vision Acquires Simovision BV, Distributor of Ophthalmic Products
November 24, 2021
Daha fazla